company insight

Lonza Pharma & Biotech – Capsule Delivery Solutions

Capsule Delivery Solutions, part of Lonza Pharma & Biotech, is the leader in capsule-based solutions and services, proudly offering Capsugel® products. With the largest production and supply chain footprint in the industry, Capsule Delivery Solutions provides the highest quality and deepest regulatory expertise to its 2,000 pharmaceutical customers, globally.

SHL Group details its approach to the challenges of emerging formulations

For more than 100 years, biopharmaceutical companies have relied on the quality, consistency and functional innovations Capsugel® has delivered; today we produces more than 200 billion capsules in over 100 countries.

Building on our history of innovation in polymer science and capsule engineering, Capsule Delivery Solutions continues to launch ground-breaking capsule designs and equipment technologies that are improving drug development and delivery. Whether you’re looking to formulate new products or enhance an existing line, we have the right capsule to help you bring improved products to market faster. With a diverse portfolio including HPMC, Dry Powder Inhalation capsules or specialized clinical capsules, we are a global leader in capsule development and manufacturing, bringing unmatched products and technical support to our worldwide customer base.

Capsule Delivery Solutions Quality 

From the purchase of key raw materials to the manufacturing, packaging and delivering of finished products, Capsule Delivery Solutions works to ensure the safety and quality of capsules we supply to pharmaceutical customers around the world.

As key elements of our quality commitment, Capsugel is investing in Regulatory Compliance Monitoring Programs that anticipates and proactively responds to the continuously evolving global food-safety standards and maintains a robust Quality System, from sourcing of our ingredients to the distribution of our products, that is compliant with all applicable standards.

Capsule Delivery Solutions offers

High quality empty capsules:

  • Immediate release: Coni-Snap® Gelatin, Vcaps® Plus, Plantcaps®
  • Targeted & Modified release: Vcaps® Enteric, DUOCAP®

  • Dry Powder Inhalation capsules: Gelatin: Coni-Snap® Gelatin and Coni-Snap® Gelatin-PEG, HPMC: Vcaps® and Vcaps® Plus

  • Preclinical and clinical development capsules: PCcaps®, DBcaps®

  • Patient Centric capsules: Coni-Snap® Sprinkle
  • Life Cycle Management solutions: Press-Fit®, XPress-Fit®

Innovative and tailored services:

Share this article

Go to article: Home | A New Class of TreatmentGo to article: EditorialGo to article: Pfanstiehl Company InsightGo to article: PfanstiehlGo to article: ContentsGo to article: Daiichi JitsugyoGo to article: NewsGo to article: DistekGo to article: The pharma industry briefingGo to article: DelSiTechGo to article: Big soil: A $1bn project to develop new drugs from earthGo to article: Novo NordiskGo to article: International Cannabis and Cannabinoid Institute (ICCI) Company InsightGo to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: medical hempGo to article: Cannabinoids breakthrough signals hope for epilepsy treatment Go to article: CBDepot Company InsightGo to article: CBDepotGo to article: Capsugel Company InsightGo to article: Could cutting out mediators let cancer research off the leash? Go to article: EcocoolGo to article: The next generation of antimalarials Go to article: AlpexGo to article:  Pharma air freight: what does it take to get certified? Go to article: PangeanicGo to article: Blocking generic competition: will naming and shaming work?Go to article: Haselmeier GmbH Company InsightGo to article: Haselmeier GmbH Go to article: EventsGo to article: Abiogen PharmaGo to article: Next issueGo to article: HOF SonderanlagenbauGo to article: EvolveGo to article: ILC Dover Inc